false
Catalog
2018 AANS Annual Scientific Meeting
596. Early VTE Chemoprophylaxis in TBI Patients Is ...
596. Early VTE Chemoprophylaxis in TBI Patients Is Safe and Effective
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
Dr. David Shin, a PGY3 at the University of Florida, discusses his research on early venous thromboembolism (VTE) prophylaxis in traumatic brain injury (TBI) patients. He notes that TBI patients are at increased risk of developing VTE due to immobility and brain injury. Current guidelines recommend the use of low molecular weight heparin or low dose unfractionated heparin in combination with mechanical prophylaxis, but there is no strong evidence to support this recommendation. Dr. Shin's study retrospectively reviewed 521 TBI patients and found that early administration of chemoprophylaxis did not result in worsening intracranial hemorrhage, and significantly reduced the incidence of DVT and/or PE. However, there were limitations to the study, including its retrospective nature and imbalance in patient groups. Overall, the study suggests that early chemoprophylaxis may be safe and effective in reducing thromboembolic events in TBI patients. No credits are mentioned.
Asset Caption
David Heegwang Shin, MD
Keywords
Dr. David Shin
early venous thromboembolism prophylaxis
traumatic brain injury patients
chemoprophylaxis
thromboembolic events
×
Please select your language
1
English